Pharming Return On Assets from 2010 to 2026
| PHARM Stock | EUR 1.40 0.01 0.71% |
Return On Assets | First Reported 2010-12-31 | Previous Quarter (0.02) | Current Value (0.03) | Quarterly Volatility 0.40075427 |
Check Pharming Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharming Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 12.3 M, Interest Expense of 6.6 M or Selling And Marketing Expenses of 7.8 M, as well as many indicators such as Price To Sales Ratio of 2.43, Dividend Yield of 0.0 or PTB Ratio of 3.82. Pharming financial statements analysis is a perfect complement when working with Pharming Group Valuation or Volatility modules.
Pharming | Return On Assets |
Analyzing Pharming Group's Return On Assets over time reveals critical patterns in financial health and operational efficiency. This metric helps investors evaluate trends, identify inflection points, and make informed decisions based on historical performance. Understanding how Return On Assets has evolved provides context for assessing Pharming Group's current valuation and future prospects.
Latest Pharming Group's Return On Assets Growth Pattern
Below is the plot of the Return On Assets of Pharming Group NV over the last few years. It is a profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets. Pharming Group's Return On Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharming Group's overall financial position and show how it may be relating to other accounts over time.
| Return On Assets | 10 Years Trend |
|
Return On Assets |
| Timeline |
Pharming Return On Assets Regression Statistics
| Arithmetic Mean | (0.22) | |
| Geometric Mean | 0.12 | |
| Coefficient Of Variation | (185.23) | |
| Mean Deviation | 0.30 | |
| Median | (0.03) | |
| Standard Deviation | 0.40 | |
| Sample Variance | 0.16 | |
| Range | 1.589 | |
| R-Value | 0.67 | |
| Mean Square Error | 0.1 | |
| R-Squared | 0.44 | |
| Significance | 0 | |
| Slope | 0.05 | |
| Total Sum of Squares | 2.57 |
Pharming Return On Assets History
About Pharming Group Financial Statements
Pharming Group stakeholders use historical fundamental indicators, such as Pharming Group's Return On Assets, to determine how well the company is positioned to perform in the future. Although Pharming Group investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pharming Group's assets and liabilities are reflected in the revenues and expenses on Pharming Group's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pharming Group NV. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Assets | (0.02) | (0.03) |
Thematic Opportunities
Explore Investment Opportunities
Check out the analysis of Pharming Group Correlation against competitors. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.